Literature DB >> 27142852

Nucleolus-derived mediators in oncogenic stress response and activation of p53-dependent pathways.

Dariusz Stępiński1.   

Abstract

Rapid growth and division of cells, including tumor ones, is correlated with intensive protein biosynthesis. The output of nucleoli, organelles where translational machineries are formed, depends on a rate of particular stages of ribosome production and on accessibility of elements crucial for their effective functioning, including substrates, enzymes as well as energy resources. Different factors that induce cellular stress also often lead to nucleolar dysfunction which results in ribosome biogenesis impairment. Such nucleolar disorders, called nucleolar or ribosomal stress, usually affect cellular functioning which in fact is a result of p53-dependent pathway activation, elicited as a response to stress. These pathways direct cells to new destinations such as cell cycle arrest, damage repair, differentiation, autophagy, programmed cell death or aging. In the case of impaired nucleolar functioning, nucleolar and ribosomal proteins mediate activation of the p53 pathways. They are also triggered as a response to oncogenic factor overexpression to protect tissues and organs against extensive proliferation of abnormal cells. Intentional impairment of any step of ribosome biosynthesis which would direct the cells to these destinations could be a strategy used in anticancer therapy. This review presents current knowledge on a nucleolus, mainly in relation to cancer biology, which is an important and extremely sensitive element of the mechanism participating in cellular stress reaction mediating activation of the p53 pathways in order to counteract stress effects, especially cancer development.

Entities:  

Keywords:  ARF/RP–Mdm2–p53 axis; Cancer; Nucleolar (ribosomal) stress; Nucleolus; Oncogenic stress

Mesh:

Substances:

Year:  2016        PMID: 27142852     DOI: 10.1007/s00418-016-1443-6

Source DB:  PubMed          Journal:  Histochem Cell Biol        ISSN: 0948-6143            Impact factor:   4.304


  231 in total

1.  Immobilization of proteins in the nucleolus by ribosomal intergenic spacer noncoding RNA.

Authors:  Timothy E Audas; Mathieu D Jacob; Stephen Lee
Journal:  Mol Cell       Date:  2012-01-27       Impact factor: 17.970

Review 2.  New insights into nucleolar architecture and activity.

Authors:  Ivan Raska; Peter J Shaw; Dusan Cmarko
Journal:  Int Rev Cytol       Date:  2006

3.  p53 is localized to a sub-nucleolar compartment after proteasomal inhibition in an energy-dependent manner.

Authors:  Orit Karni-Schmidt; Andrew Zupnick; Mirela Castillo; Aqeel Ahmed; Tulio Matos; Philippe Bouvet; Carlos Cordon-Cardo; Carol Prives
Journal:  J Cell Sci       Date:  2008-11-25       Impact factor: 5.285

Review 4.  Targeting the nucleolus for cancer intervention.

Authors:  Jaclyn E Quin; Jennifer R Devlin; Donald Cameron; Kate M Hannan; Richard B Pearson; Ross D Hannan
Journal:  Biochim Biophys Acta       Date:  2014-01-02

Review 5.  Pharmacological activation of the p53 pathway in haematological malignancies.

Authors:  Manujendra N Saha; Johann Micallef; Lugui Qiu; Hong Chang
Journal:  J Clin Pathol       Date:  2009-12-02       Impact factor: 3.411

6.  Physical and functional interactions of the Arf tumor suppressor protein with nucleophosmin/B23.

Authors:  David Bertwistle; Masataka Sugimoto; Charles J Sherr
Journal:  Mol Cell Biol       Date:  2004-02       Impact factor: 4.272

7.  Disruption of the nucleolus mediates stabilization of p53 in response to DNA damage and other stresses.

Authors:  Carlos P Rubbi; Jo Milner
Journal:  EMBO J       Date:  2003-11-17       Impact factor: 11.598

8.  Nucleophosmin interacts directly with c-Myc and controls c-Myc-induced hyperproliferation and transformation.

Authors:  Zhaoliang Li; David Boone; Stephen R Hann
Journal:  Proc Natl Acad Sci U S A       Date:  2008-11-24       Impact factor: 11.205

9.  Site of transcription of ribosomal RNA and intranucleolar structure in HeLa cells.

Authors:  P Hozák; P R Cook; C Schöfer; W Mosgöller; F Wachtler
Journal:  J Cell Sci       Date:  1994-02       Impact factor: 5.285

Review 10.  Perturbations at the ribosomal genes loci are at the centre of cellular dysfunction and human disease.

Authors:  Jeannine Diesch; Ross D Hannan; Elaine Sanij
Journal:  Cell Biosci       Date:  2014-08-19       Impact factor: 7.133

View more
  12 in total

Review 1.  Ribosome Biogenesis in Plants: From Functional 45S Ribosomal DNA Organization to Ribosome Assembly Factors.

Authors:  Julio Sáez-Vásquez; Michel Delseny
Journal:  Plant Cell       Date:  2019-06-25       Impact factor: 11.277

2.  Perturbation of RNA Polymerase I transcription machinery by ablation of HEATR1 triggers the RPL5/RPL11-MDM2-p53 ribosome biogenesis stress checkpoint pathway in human cells.

Authors:  Zsofia Turi; Marketa Senkyrikova; Martin Mistrik; Jiri Bartek; Pavel Moudry
Journal:  Cell Cycle       Date:  2017-12-10       Impact factor: 4.534

3.    In Focus in HCB.

Authors:  Douglas J Taatjes; Jürgen Roth
Journal:  Histochem Cell Biol       Date:  2016-07-06       Impact factor: 4.304

4.  NOL6, a new founding oncogene in human prostate cancer and targeted by miR-590-3p.

Authors:  Degang Dong; Mei Song; Xiaoli Wu; Wanchun Wang
Journal:  Cytotechnology       Date:  2020-04-05       Impact factor: 2.058

5.  Ribosomal protein L6 (RPL6) is recruited to DNA damage sites in a poly(ADP-ribose) polymerase-dependent manner and regulates the DNA damage response.

Authors:  Chuanzhen Yang; Weicheng Zang; Yapeng Ji; Tingting Li; Yongfeng Yang; Xiaofeng Zheng
Journal:  J Biol Chem       Date:  2018-12-31       Impact factor: 5.157

6.  Prohibitin 2 localizes in nucleolus to regulate ribosomal RNA transcription and facilitate cell proliferation in RD cells.

Authors:  Zilong Zhou; Huihan Ai; Kun Li; Xinlei Yao; Wenbin Zhu; Lei Liu; Chunlei Yu; Zhenbo Song; Yongli Bao; Yanxin Huang; Yin Wu; Lihua Zheng; Ying Sun; Guannan Wang; Kewei Ma; Luguo Sun; Yuxin Li
Journal:  Sci Rep       Date:  2018-01-24       Impact factor: 4.379

Review 7.  Treating hematological malignancies with drugs inhibiting ribosome biogenesis: when and why.

Authors:  Enrico Derenzini; Alessandra Rossi; Davide Treré
Journal:  J Hematol Oncol       Date:  2018-05-31       Impact factor: 17.388

8.  Mouse adult hematopoietic stem cells actively synthesize ribosomal RNA.

Authors:  Léonard Jarzebowski; Marie Le Bouteiller; Sabrina Coqueran; Aurélien Raveux; Sandrine Vandormael-Pournin; Alexandre David; Ana Cumano; Michel Cohen-Tannoudji
Journal:  RNA       Date:  2018-09-21       Impact factor: 4.942

9.  HEATR1 modulates cell survival in non-small cell lung cancer via activation of the p53/PUMA signaling pathway.

Authors:  Saifei He; Xing Ma; Ying Ye; Miao Zhang; Juhua Zhuang; Yanan Song; Wei Xia
Journal:  Onco Targets Ther       Date:  2019-05-21       Impact factor: 4.147

Review 10.  The nucleolus, an ally, and an enemy of cancer cells.

Authors:  Dariusz Stępiński
Journal:  Histochem Cell Biol       Date:  2018-08-13       Impact factor: 4.304

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.